Pesticides & Agrochemicals · Founded 1975 · www.punjabchemicals.com · BSE 506618 · NSE PUN.CHEM · ISIN INE277B01014
No Notes Added Yet
Business
Punjab Chemicals & Crop Protection Ltd. (PCCPL) is an Indian manufacturer of agrochemicals and specialty chemicals. Its core business involves the production of a wide range of technical-grade pesticides (insecticides, fungicides, herbicides) and their formulations, catering to the crop protection needs of farmers. Additionally, the company manufactures industrial chemicals, pharmaceutical intermediates, and other specialty chemicals. PCCPL operates on a business-to-business (B2B) model, supplying technicals and formulations to other agrochemical companies, and a business-to-consumer (B2C) model through its own branded formulations distributed to farmers. It generates revenue through the sale of these chemical products in both domestic and international markets.
Revenue Mix
While specific percentage breakdowns can vary year-to-year and are not always prominently displayed in easily accessible public documents, PCCPL's revenue primarily derives from two main categories:
Agrochemicals: This segment includes technical-grade pesticides and their formulations (insecticides, herbicides, fungicides, plant growth regulators). This is the dominant segment.
Specialty Chemicals/Other: This segment includes pharmaceutical intermediates and other industrial chemicals.
The company has a significant presence in both the domestic Indian market and international markets through exports. Historically, exports have contributed substantially to total revenue.
Industry
The Indian Pesticides & Agrochemicals industry is one of the largest globally, characterized by a mix of large multinational corporations, established domestic players, and numerous smaller enterprises. It is highly competitive and regulated. Punjab Chemicals & Crop Protection Ltd. positions itself as an integrated player with manufacturing capabilities for both technicals and formulations. It competes with other mid-to-large Indian agrochemical companies like UPL, PI Industries, Bharat Rasayan, and Excel Industries. The company focuses on a diversified product portfolio and a blend of domestic and export sales, often capitalizing on its R&D capabilities for process improvements and developing off-patent molecules.
MOAT
Manufacturing Expertise & Scale: PCCPL possesses established manufacturing facilities and process chemistry expertise in complex chemical synthesis, allowing for cost-effective production of a range of agrochemical intermediates and technicals.
Regulatory Know-how: Navigating the stringent regulatory environment for product registration and manufacturing approvals in agrochemicals, both domestically and internationally, acts as a barrier to entry for new players.
Diversified Product Portfolio: A broad range of products across different crop segments and chemistries reduces dependence on a single product or market.
Customer Relationships: Long-standing relationships with domestic and international clients, particularly for technicals, can create some switching costs for buyers.
Growth Drivers
Increasing Food Demand: Growing global population and demand for food will drive the need for enhanced agricultural productivity, thereby increasing the consumption of crop protection products.
Exports Opportunity: India's position as a low-cost manufacturing hub for off-patent agrochemicals, coupled with global supply chain diversification trends, presents significant export growth potential.
R&D and New Product Introductions: Development of new molecules, improved formulations, and process innovations can open new markets and increase market share.
Focus on Specialty Chemicals: Expanding the presence in higher-margin specialty chemicals and pharmaceutical intermediates can diversify revenue streams and improve profitability.
Farmer Awareness and Intensification: Rising awareness among Indian farmers about the benefits of crop protection and increasing farming intensity contribute to domestic demand growth.
Risks
Monsoon Dependence: The performance of the Indian agricultural sector is heavily reliant on the monsoon, directly impacting domestic demand for agrochemicals.
Regulatory Changes: Stringent environmental regulations, bans on certain pesticides, or changes in registration processes by Indian or international authorities can impact product portfolios and profitability.
Raw Material Price Volatility: Fluctuations in the prices of key raw materials (many derived from crude oil or other basic chemicals) can impact manufacturing costs and margins.
Intense Competition: The industry is highly competitive, leading to pricing pressures and potential erosion of market share.
Currency Fluctuations: As a significant exporter, adverse movements in foreign exchange rates can impact export realizations.
Environmental and Safety Risks: Manufacturing chemicals involves inherent risks related to environmental compliance, industrial safety, and potential liabilities.
Management & Ownership
Punjab Chemicals & Crop Protection Ltd. is promoted by the Shroff family, with the promoter group holding a significant stake in the company, typical for many Indian businesses. Mr. S.K. Shroff is a key figure in the management. Management quality is generally perceived through its ability to navigate the cyclical agrochemical industry, manage R&D, and maintain manufacturing efficiency. The promoter holding provides stability but also means decisions are often influenced by family interests. Institutional and public ownership make up the remainder of the shares.
Outlook
PCCPL operates in an essential sector, benefiting from the fundamental global and domestic demand for food and agricultural produce. The company's integrated manufacturing capabilities, diversified product portfolio, and presence in both domestic and export markets provide a stable foundation. Growth opportunities are present through increasing export demand, new product development, and a gradual shift towards higher-value specialty chemicals. However, the business faces inherent risks such as dependence on monsoon, raw material price volatility, and evolving regulatory landscapes. The ability to successfully navigate these challenges, manage working capital efficiently, and continue investing in R&D and capacity expansion will be crucial for sustained performance in the highly competitive agrochemical space.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 197 | 242 | 242 | 214 | 202 | 320 | 255 | 247 | 209 | 347 |
| Other Income | 1 | 1 | 2 | 0 | 0 | 4 | 6 | 2 | 2 | 1 |
| Total Income | 197 | 243 | 244 | 214 | 203 | 323 | 261 | 249 | 211 | 348 |
| Total Expenditure | 183 | 215 | 217 | 195 | 177 | 285 | 229 | 217 | 181 | 306 |
| Operating Profit | 14 | 28 | 27 | 19 | 26 | 38 | 32 | 32 | 30 | 41 |
| Interest | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 5 | 4 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 9 | 7 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -4 | 0 | 0 | -2 | 0 | 0 |
| Profit Before Tax | 4 | 18 | 17 | 8 | 10 | 28 | 22 | 19 | 16 | 30 |
| Provision for Tax | 1 | 5 | 4 | 2 | 3 | 7 | 3 | 5 | 5 | 8 |
| Profit After Tax | 2 | 13 | 12 | 6 | 7 | 21 | 19 | 14 | 11 | 22 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 13 | 12 | 6 | 7 | 21 | 19 | 14 | 11 | 22 |
| Adjusted Earnings Per Share | 2 | 11 | 10.1 | 5 | 5.8 | 16.8 | 15.1 | 11.3 | 9 | 18 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 538 | 525 | 493 | 643 | 550 | 678 | 933 | 1006 | 934 | 901 | 1030 | 1058 |
| Other Income | 16 | 13 | 11 | 7 | 13 | 2 | 1 | 3 | 3 | 1 | 14 | 11 |
| Total Income | 554 | 537 | 504 | 650 | 563 | 680 | 934 | 1010 | 937 | 902 | 1043 | 1069 |
| Total Expenditure | 497 | 510 | 452 | 577 | 507 | 583 | 794 | 884 | 821 | 801 | 912 | 933 |
| Operating Profit | 57 | 28 | 53 | 73 | 56 | 97 | 141 | 126 | 116 | 101 | 132 | 135 |
| Interest | 50 | 31 | 18 | 17 | 18 | 13 | 12 | 18 | 21 | 18 | 17 | 17 |
| Depreciation | 17 | 16 | 14 | 19 | 15 | 15 | 17 | 19 | 22 | 25 | 29 | 30 |
| Exceptional Income / Expenses | 24 | 0 | 3 | -8 | 0 | 0 | 0 | 0 | 0 | -4 | -2 | -2 |
| Profit Before Tax | 14 | -19 | 24 | 29 | 22 | 69 | 112 | 89 | 73 | 54 | 84 | 87 |
| Provision for Tax | 1 | 1 | 7 | 12 | 11 | 20 | 28 | 28 | 20 | 15 | 20 | 21 |
| Profit After Tax | 13 | -20 | 17 | 17 | 11 | 49 | 83 | 61 | 54 | 39 | 64 | 66 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 13 | -20 | 17 | 17 | 11 | 49 | 83 | 61 | 54 | 39 | 64 | 66 |
| Adjusted Earnings Per Share | 10.8 | -16.3 | 14 | 13.7 | 8.8 | 40 | 68.1 | 49.8 | 43.7 | 31.8 | 52.2 | 53.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 14% | 1% | 9% | 7% |
| Operating Profit CAGR | 31% | 2% | 6% | 9% |
| PAT CAGR | 64% | 2% | 5% | 17% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -28% | -2% | -8% | 17% |
| ROE Average | 16% | 15% | 23% | 14% |
| ROCE Average | 18% | 18% | 26% | 24% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 61 | 58 | 74 | 91 | 98 | 145 | 226 | 281 | 330 | 365 | 423 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 106 | 67 | 48 | 11 | 40 | 70 | 58 | 64 | 53 | 70 | 46 |
| Other Non-Current Liabilities | 59 | 7 | 15 | 33 | 42 | 38 | 38 | 41 | 35 | 41 | 65 |
| Total Current Liabilities | 231 | 296 | 215 | 247 | 229 | 228 | 283 | 313 | 330 | 415 | 409 |
| Total Liabilities | 457 | 428 | 353 | 382 | 409 | 480 | 605 | 699 | 748 | 891 | 943 |
| Fixed Assets | 235 | 198 | 152 | 161 | 168 | 189 | 212 | 222 | 236 | 253 | 275 |
| Other Non-Current Assets | 40 | 50 | 41 | 46 | 44 | 44 | 37 | 46 | 41 | 46 | 85 |
| Total Current Assets | 183 | 180 | 160 | 175 | 197 | 247 | 355 | 430 | 471 | 591 | 583 |
| Total Assets | 457 | 428 | 353 | 382 | 409 | 480 | 605 | 699 | 748 | 891 | 943 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 14 | -41 | -44 | -44 | 1 | 2 | 12 | 8 | 9 | 6 | 13 |
| Cash Flow from Operating Activities | 105 | 62 | 61 | 68 | 34 | 43 | 34 | 58 | 30 | 25 | 86 |
| Cash Flow from Investing Activities | 11 | -8 | -15 | -21 | -14 | -8 | -27 | -36 | -36 | -30 | -44 |
| Cash Flow from Financing Activities | -141 | -61 | -43 | -4 | -19 | -24 | -11 | -20 | 4 | 12 | -44 |
| Net Cash Inflow / Outflow | -26 | -7 | 4 | 44 | 2 | 11 | -4 | 2 | -2 | 7 | -2 |
| Closing Cash & Cash Equivalent | 5 | -44 | -44 | 1 | 2 | 12 | 8 | 9 | 6 | 13 | 9 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10.83 | -16.26 | 14.01 | 13.7 | 8.77 | 40.03 | 68.08 | 49.84 | 43.7 | 31.75 | 52.17 |
| CEPS(Rs) | 24.49 | -3.16 | 25.38 | 28.87 | 21.29 | 52.15 | 81.67 | 65.34 | 61.78 | 52.18 | 75.53 |
| DPS(Rs) | 0 | 0 | 0 | 1.5 | 1.5 | 2 | 3 | 3 | 3 | 3 | 3 |
| Book NAV/Share(Rs) | 6.25 | 47.63 | 60.5 | 74.11 | 79.73 | 117.89 | 184.03 | 228.89 | 269.3 | 297.48 | 345.41 |
| Core EBITDA Margin(%) | 7.38 | 2.78 | 8.39 | 10.33 | 7.72 | 14.08 | 14.96 | 12.18 | 12.14 | 11.01 | 11.47 |
| EBIT Margin(%) | 11.52 | 2.14 | 8.46 | 7.16 | 7.32 | 12.16 | 13.28 | 10.63 | 10.05 | 7.92 | 9.81 |
| Pre Tax Margin(%) | 2.51 | -3.58 | 4.89 | 4.47 | 4.02 | 10.18 | 11.96 | 8.83 | 7.82 | 5.94 | 8.18 |
| PAT Margin (%) | 2.41 | -3.72 | 3.46 | 2.61 | 1.96 | 7.24 | 8.94 | 6.07 | 5.74 | 4.32 | 6.21 |
| Cash Profit Margin (%) | 5.45 | -0.72 | 6.28 | 5.51 | 4.75 | 9.43 | 10.73 | 7.96 | 8.11 | 7.1 | 8.99 |
| ROA(%) | 2.83 | -4.5 | 4.4 | 4.57 | 2.72 | 11.05 | 15.39 | 9.38 | 7.41 | 4.75 | 6.97 |
| ROE(%) | 0 | -60.35 | 25.92 | 20.36 | 11.4 | 40.52 | 45.1 | 24.14 | 17.54 | 11.21 | 16.23 |
| ROCE(%) | 26.16 | 5.62 | 20.93 | 24.65 | 21.21 | 38.41 | 44.96 | 30.83 | 22.7 | 14.49 | 18.21 |
| Receivable days | 49.61 | 47.51 | 38.89 | 29.77 | 36.63 | 35.39 | 38.26 | 46.27 | 66.56 | 87.65 | 77.75 |
| Inventory Days | 43.93 | 41.44 | 48.3 | 42.18 | 55.82 | 50.53 | 49.86 | 58.4 | 58.78 | 71.9 | 82.93 |
| Payable days | 80.27 | 111.02 | 136.11 | 100.97 | 113.67 | 91.43 | 78.74 | 77.78 | 81.97 | 108.34 | 110.63 |
| PER(x) | 12.83 | 0 | 27.77 | 50.47 | 34.39 | 21.86 | 21.4 | 16.61 | 22.48 | 29.26 | 16.99 |
| Price/Book(x) | 22.25 | 5.86 | 6.43 | 9.33 | 3.78 | 7.42 | 7.92 | 3.62 | 3.65 | 3.12 | 2.57 |
| Dividend Yield(%) | 0 | 0 | 0 | 0.22 | 0.5 | 0.23 | 0.21 | 0.36 | 0.31 | 0.32 | 0.34 |
| EV/Net Sales(x) | 0.66 | 0.94 | 1.19 | 1.46 | 0.84 | 1.69 | 2 | 1.09 | 1.41 | 1.43 | 1.19 |
| EV/Core EBITDA(x) | 6.27 | 17.82 | 11.18 | 12.82 | 8.35 | 11.78 | 13.29 | 8.72 | 11.35 | 12.81 | 9.3 |
| Net Sales Growth(%) | -4.76 | -2.47 | -6 | 30.35 | -14.52 | 23.4 | 37.64 | 7.79 | -7.15 | -3.61 | 14.36 |
| EBIT Growth(%) | 29.05 | -81.92 | 265.33 | 9.73 | -12.6 | 105.05 | 50.3 | -13.75 | -12.15 | -23.98 | 41.58 |
| PAT Growth(%) | -4.05 | -250.08 | 186.2 | -2.21 | -36.01 | 356.56 | 70.05 | -26.79 | -12.31 | -27.34 | 64.29 |
| EPS Growth(%) | -6.48 | -250.08 | 186.2 | -2.21 | -36.01 | 356.56 | 70.05 | -26.79 | -12.31 | -27.34 | 64.29 |
| Debt/Equity(x) | 24.99 | 2.59 | 1.58 | 1.01 | 1.01 | 0.61 | 0.41 | 0.33 | 0.37 | 0.46 | 0.36 |
| Current Ratio(x) | 0.79 | 0.61 | 0.74 | 0.71 | 0.86 | 1.08 | 1.26 | 1.37 | 1.43 | 1.42 | 1.42 |
| Quick Ratio(x) | 0.54 | 0.39 | 0.43 | 0.38 | 0.49 | 0.64 | 0.71 | 0.84 | 1.02 | 0.89 | 0.82 |
| Interest Cover(x) | 1.28 | 0.37 | 2.37 | 2.67 | 2.22 | 6.13 | 10.04 | 5.93 | 4.51 | 4 | 6.01 |
| Total Debt/Mcap(x) | 1.12 | 0.44 | 0.24 | 0.11 | 0.27 | 0.08 | 0.05 | 0.09 | 0.1 | 0.15 | 0.14 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.24 | 39.24 | 39.24 |
| FII | 3.02 | 2.97 | 2.94 | 3.06 | 2.99 | 3.02 | 3.01 | 3.01 | 5.86 | 6.66 |
| DII | 0.41 | 0.38 | 0.5 | 0.54 | 0.54 | 0.56 | 0.56 | 0.62 | 0.63 | 0.74 |
| Public | 57.35 | 57.43 | 57.34 | 57.18 | 57.25 | 57.21 | 57.22 | 57.14 | 54.27 | 53.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| FII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.08 |
| DII | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.67 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +14% | +1% | +9% | +7% |
| Operating Profit CAGR | +31% | +2% | +6% | +9% |
| PAT CAGR | +64% | +2% | +5% | +17% |
| Share Price CAGR | -28% | -2% | -8% | +17% |
| ROE Average | +16% | +15% | +23% | +14% |
| ROCE Average | +18% | +18% | +26% | +24% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.22 | 39.24 | 39.24 | 39.24 |
| FII | 3.02 | 2.97 | 2.94 | 3.06 | 2.99 | 3.02 | 3.01 | 3.01 | 5.86 | 6.66 |
| DII | 0.41 | 0.38 | 0.5 | 0.54 | 0.54 | 0.56 | 0.56 | 0.62 | 0.63 | 0.74 |
| Public | 57.35 | 57.43 | 57.34 | 57.18 | 57.25 | 57.21 | 57.22 | 57.14 | 54.27 | 53.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| FII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.08 |
| DII | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.67 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.